Multicentre,Randomized,Double-blind, Multiple-dose, Placebo-controlled, Parallel-Group Trial of Qideng Mingmu Capsule in The Treatment of Diabetic Retinopathy With Blood Stasis Syndrome and Deficiency of Qi-Yin Syndrome
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Traditional Chinese medicine
- Indications Diabetic retinopathy
- Focus Therapeutic Use
- 13 May 2013 Biomarkers information updated
- 01 Mar 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Jun 2011 New trial record